Saibal Kumar Das
Dr. Reddy's Laboratories
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Saibal Kumar Das.
Carbohydrate Research | 2003
Saibal Kumar Das; Joyita Roy; Kalusani Anantha Reddy; Chandrasekhar Abbineni
The efficiency of glycosidation reactions generally involves a high chemical yield, as well as high/complete stereo- and regioselectivity. All these depend on the compatibility of the reactivity of glycosyl donors and acceptors. Among glycosyl donors, thioglycosides are widely used because of their high degree of stability in many organic reactions. Although there are number of methods available for the preparation of thioglycosides, all of them have one or more disadvantages, especially concerning the time factor and cumbersome workup procedures. Here we report a convenient and high-yielding method for the preparation of thioglycosides.
Tetrahedron Letters | 2003
Saibal Kumar Das; K. Anantha Reddy; Chandrasekhar Abbineni; Joyita Roy; K.V.L.Narasimha Rao; Rachna H. Sachwani; Javed Iqbal
Abstract Indium(III) chloride-catalyzed, microwave-assisted Ferrier rearrangement of different per-O-acetylglycals leads to an efficient synthesis of 2,3-unsaturated C-glycosides in good to excellent yields.
Mini-reviews in Medicinal Chemistry | 2005
Javed Iqbal; Rashmi Sanghi; Saibal Kumar Das
Endothelins (ETs) are potent vasoconstrictor peptides and are associated with several disease states like pulmonary hypertension, systemic hypertension and heart failure. Endothelin-1 (ET-1) is the first member of the family and it has the receptor subtypes known as ETA and ETB. The receptors ETA and ETB are attractive new therapeutic targets for diseases associated with elevated ET-1 levels. Several studies have thus led to the discovery of selective ETA receptor antagonists as well as non-selective ETA/ETB antagonists. The preclinical and clinical studies have clearly established that these antagonists are effective in the treatment of essential hypertension, pulmonary hypertension, heart failure and atherosclerosis. The advances in this area have resulted in the FDA approval of the orally active dual antagonist Bosentan for pulmonary hypertension in 2001. This review highlights the synthesis and structure-activity of the endothelin receptor antagonists and covers the literature in this area up to 2001.
Synthetic Communications | 2004
Ashwani Kumar Sharma; Saibal Kumar Das
Abstract Microwave‐induced syntheses of sulfonamides, without using base under solvent‐free conditions, have been developed. The process finds its utility because of its simple operational procedure and high yields. Moreover, the process is fast and accommodative to different substituents on aromatic as well as heteroaromatic rings rendering sulfonamides (28 examples). #DRL‐Publication No. 327.
Journal of Organic Chemistry | 2003
D. Bahulayan; Saibal Kumar Das; Javed Iqbal
Carbohydrate Research | 2005
Saibal Kumar Das; K. Anantha Reddy; V.L. Narasimha Rao Krovvidi; K. Mukkanti
Archive | 2002
Debnath Bhuniya; Saibal Kumar Das; Gurram Ranga Madhavan; Javed Iqbal; Ranjan Chakrabarti
Archive | 2002
Javed Iqbal; Gurram Ranga Madhavan; Saibal Kumar Das; Debnath Bhunia; Ranjan Chakrabarti; Ramanujam Rajagopalan
Carbohydrate Research | 2007
Saibal Kumar Das; K. Anantha Reddy; K. Mukkanti
Archive | 2002
Bhuniya Debnath; Saibal Kumar Das; Gurram Ranga Madhavan; Javed Iqbal; Ranjan Chakrabarti; Reeba K. Vikramadithyan